News
2026-09-29
Cellectricon strengthens intellectual property portfolio with patent grant in Japan
MÖLNDAL, SWEDEN Cellectricon is pleased to announce that the Japan Patent Office has granted Japanese Patent No. 7893748, protecting the...
Events
October 22, 2026
Live webinar - In vitro neuronal models for assessment of delayed onset neuroinflammatory toxicity effects of ASOs
This webinar takes place on Thursday October 22nd at 11.00-11.30 CEST / 18.00-18.30 JST.
Events
October 11-14, 2026
2026 OTS Meeting
The 22nd Annual Meeting of the Oligonucleotide Therapeutics Society (OTS Meeting) takes place in Denver, US on October 11-14. The...

Sign up to get news & events updates from Cellectricon

Read about our Privacy Policy

Events
October 7-9, 2026
BioJapan
BioJapan takes place in Yokohama, Japan on October 7-9, 2026. The meeting is held in parallel with Regenerative Medicine Japan...
Events
September 29, 2026
Live webinar - In vitro modelling of proteopathy – a high-capacity assay for discovering modulators of alpha-synuclein aggregation
This webinar takes place on Tuesday September 29 between 16.00 and 16.30 CEST / 15.00-15.30 GMT / 10.00-10.30 AM EDT / 7.00-7.30 AM...
Events
September 21-23, 2026
Safety Pharmacology Society Annual Meeting
The SPS Annual Meeting takes place in Montréal, Canada on September 21-23 for a scientific program under the theme Novel...

Sign up to get news & events updates from Cellectricon

Read about our Privacy Policy

Events
September 8, 2026
Live webinar - A translationally relevant assay platform for assessment of acute onset antisense oligonucleotide-induced neurotoxicity
This webinar takes place on Tuesday September 8th at 11.00-11.30 CEST / 18.00-18.30 JST.
Events
July 8, 2026
Live webinar - Optical electrophysiology for in vitro investigations of neuronal excitability in chronic pain research
This webinar takes place on Wednesday July 8th between 16.00 and 16.30 CEST / 15.00-15.30 GMT / 10.00-10.30 AM EDT / 7.00-7.30 AM...
Events
June 23, 2026
Live webinar - In vitro neuronal models for assessment of acute and delayed onset toxicity effects of oligonucleotide-based drugs
This webinar takes place on Tuesday June 23rd at 11.00-11.30 CEST / 18.00-18.30 JST.